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Introduction. Branch retinal vein occlusion (BRVO) is a common retinal vascular condition that results in intraocular inflammatory
changes. Ultra wide field fluorescein angiography (UWFFA) is a retinal imaging device that can capture peripheral retinal findings.
The purpose of this study was to look for peripheral findings in the fellow eye of patients with BRVO using UWFFA. Methods.
Retrospective imaging review of patients diagnosed with BRVO that had both eyes imaged with UWFFA. Images were graded for
peripheral findings in other quadrants of the same eye as well as in all quadrants of the fellow eye. Results. Of 81 patients, 14 (17%)
patients had late vascular leakage in a quadrant other than the BRVO distribution. Five (6%) findings were in the same eye, 8 (10%)
findings were in the fellow eye, and 1 (1%) finding was in both the same eye and the fellow eye. Of these 14 patients, 11 (80%) patients
had hypertension. Conclusion. Late peripheral retinal leakage in the fellow eye of patients with BRVO was detected in this cohort
of patients with UWFFA. This novel finding may represent underlying systemic inflammation, hypertension, or bilateral BRVOs.
1. Introduction
Branch retinal vein occlusion (BRVO) affects approximately
1% of the population and can cause severe vision loss
throughmacular edema, retinal neovascularization, and reti-
nal detachment [1–4]. The disease is estimated to be bilateral
in 5% of patients at presentation and become bilateral in 15%
of patients over time [3, 5]. When bilateral and/or multiple,
systemic vasculitis such as sarcoidosis, systemic lupus erythe-
matosus, or Behcet’s disease may be the underlying etiology.
Atherosclerosis risk factors such as hypertension and
hypercholesterolemia are thought to contribute to BRVO for-
mation by causing arterial wall hardening and inflammation
at arteriovenous crossing sites [6]. In theory, systemic risk
factors should put patients at similar risk for BRVO in both
eyes and it is unclear why the disease is typically unilateral.
One explanation could be due to random and individual
variation in arteriovenous crossing patterns [7].
There are several studies examining the vitreous of eyes
that have suffered BRVO showing that there are increased
inflammatory mediators when compared with control sur-
gical patients. For example, vascular endothelial growth
factor (VEGF), soluble intercellular adhesion molecule-1,
interleukin-8, and interleukin-6 were among the inflamma-
tory markers found to be elevated in the vitreous of BRVO
eyes [8–10]. In these studies inflammatory markers were
correlated to macular edema [10] and the size of BRVO
[8]. However, vitreous samples were not taken before BRVO
was detected nor was the vitreous of the fellow eye assessed
as vitreous removal is invasive and there was no clinical
indication. Therefore, it is not certain if the increase in
inflammatory markers was a cause or effect of the disease.
Ultra wide field fluorescein angiography (UWFFA,
Optos, Marlborough, MA, USA) is a retinal imaging tech-
nology that captures up to 200 degrees of the retina in a
single picture and has been useful in detecting peripheral
findings in a variety of retinal vascular diseases including
diabetes, vein occlusions, and uveitis [11–13]. Prior work by
our group studying peripheral retinal findings in BRVOusing
UWFFA found that peripheral nonperfusion and vascular
leakage were detectable [11]. In a cohort of 80 patients,
peripheral nonperfusion was associated with angiographic
macular edema, while vascular leakage was not. The purpose
of this current study was to assess peripheral findings on
2 International Journal of Inflammation
Figure 1: Ultra wide field fluorescein angiogram of an eye with
a superotemporal branch retinal vein occlusion. There is also late
peripheral leakage in the inferotemporal quadrant.
fluorescein angiography in other quadrants of the same eye
and in fellow eyes of patients with BRVO.
2. Materials and Methods
This retrospective imaging study was Institutional Review
Board approved and carried out at the Jules Stein Eye Institute
in Los Angles, CA, USA. An imaging database was searched
for patients with the diagnosis of BRVO who underwent
UWFFA (Optos, Marlborough, MA, USA). Patients with
another diagnosis or with concurrent other retinal dis-
eases (i.e., age-related macular degeneration) were excluded.
Patients with poorly controlled diabetes or signs of diabetic
retinopathy such as intraretinal hemorrhage and venous
beading were excluded. Patients with known inflammatory
disorders such as sarcoidosis, systemic lupus erythematosus,
and Behcet’s disease were excluded.
Demographic data such as patient gender and age were
collected. Significant past medical history such as hyperten-
sion, high cholesterol, and diabetes mellitus were noted. All
images were reviewed with Vantage Review Software (Optos,
Marlborough, MA, USA) and adjusted with zoom, gamma,
and contrast to optimize image quality.The quadrant affected
by a BRVO was recorded. Other quadrants of the same eye
were assessed for peripheral findings. Similarly, all quadrants
of the fellow eye were graded for peripheral findings.
3. Results
A total of 84 patients with BRVO were included in this study.
Forty-nine (58%) patientswere female and 55 (65%) eyeswere
OD. Average patient age was 60 years old (range 34–94 years;
SD 13 years). Sixteen (19%) patients had no significant past
medical history. Thirty-eight (45%) patients had hyperten-
sion only.Nineteen (23%) patients had hypertension and high
cholesterol only. Five (6%) patients had hypertension and
diabetes mellitus only. Four (5%) patients had hypertension,
high cholesterol, and diabetesmellitus. Two (2%) patients had
diabetes mellitus only.
Thirteen (15%) BRVOs were macular and 71 (85%) were
quadrantic. Of the macular BRVOs, 10 (77%) were superior
(a)
(b)
Figure 2: (a) Ultra wide field angiogram of a patient with branch
retinal vein occlusion in the right eye. (b) The fellow eye has late
peripheral leakage temporally.
and 3 (23%) were inferior. Of the quadrantic BRVOs, 40
(56%) were superotemporal, 25 (35%) were inferotemporal, 3
(4%) were inferonasal, and 1 (1%) was superonasal. Two (3%)
patients had two quadrantic BRVOs in the same eye.
Three (4%) patients were known to have bilateral BRVOs
at the time of presentation. Of the remaining 81 patients, 14
(17%) patients had late vascular leakage in a quadrant other
than the BRVO distribution. Five (6%) findings were in the
same eye, 8 (10%) findings were in the fellow eye, and 1 (1%)
finding was in both the same eye and the fellow eye. The six
eyes (7%) with leakage in the same eye all had leakage in a
quadrant contiguous to the BRVO. Of the 14 patients with
leakage in a quadrant other than the BRVO, 8 (57%) patients
had hypertension only; 2 (14%) patients had hypertension,
high cholesterol, and diabetes mellitus; 1 (7%) patient had
hypertension and diabetes mellitus only; 1 (7%) patient had
high cholesterol only; and 2 (14%) patients had no known
systemic diseases.
4. Discussion
This study examined peripheral retinal changes in patients
with BRVO in other quadrants of the same eye and in the
fellow eye using UWFFA. In 81 patients, 14 (17%) patients
had late vascular leakage in a quadrant other than the BRVO
distribution. Two examples from our study are shown in
Figures 1 and 2.
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There are three explanations for detecting late peripheral
leakage in 11% (𝑛 = 9) of fellow eyes. One possibility
is that inflammation is not only a consequence of vein
occlusion, but it is also a part of the pathogenesis of BRVO
and patients with BRVO have higher levels of inflammation
systemically. This hypothesis has been tested by examining
gene polymorphisms related to inflammatory cytokines in
BRVO patients and normal control patients [14]. In a study
of almost 400 patients, 10 single nucleotide polymorphisms
were assayed but were not found to be independent risk
factors for BRVO suggesting that inflammation did not
contribute to the pathogenesis of BRVO.
A multiethnic epidemiological study of over 6000 sub-
jects considered the association of retinal vein occlusion
(RVO) to traditional cardiovascular risk factors [1]. RVO was
not associated with systemic inflammation, hematological
abnormalities, or atherosclerosis but it was associated with
hypertension and dyslipidemia. Given the high prevalence of
hypertension in our group of patients, a second explanation
for late peripheral leakage in the fellow eye is that it was a
manifestation of hypertension.
A third explanation of bilateral leakage is that BRVOmay
be underrecognized as a bilateral disease and these areas of
late peripheral leakage are actually small peripheral BRVOs
that are otherwise undetectable with clinical exam and
traditional imaging. This would be supported by the fact that
the distribution of leakage was often in a venous distribution.
Without coexisting macular edema or peripheral ischemia,
small incidentally found BRVOs do not require treatment
but the finding does warrant further observation to detect
progression of disease.
Lastly, it is possible that these small areas of peripheral
vascular leakage are not pathological andmay be found in the
general population. To our knowledge, there is no prior study
establishing UWFFA findings in healthy patients without
known ocular or systemic disease. In 1985, a study using
traditional fluorescein angiography in 25 patients did not
detect peripheral leakage in normal patients [15]. However,
this was before UWFFAwas available and likely incompletely
captured the periphery.
Limitations of our study are related to its retrospective
nature, sample size, and lack of a control group. Some patients
had anti-VEGF treatment within two months of having
UWFFA and this may have masked leakage in the treated
eye. It is possible that patients with unexpected peripheral
leakage do in fact have a coexisting systemic illness that
was not documented in the chart. Furthermore, patients
at a tertiary referral center may not represent the general
population. Nonetheless, a subset of patients were found
to have unexpected late peripheral leakage on UWFFA of
possible clinical significance.
In conclusion, 11% of patients with BRVO in our popu-
lation had unexpected late peripheral leakage in fellow eyes
on UWFFA. It may represent an underlying inflammatory
condition, hypertensive changes, or bilateral BRVO. Further
studies to evaluate a larger population of BRVO patients in
a protocol manner should be considered to further elucidate
the significance of these findings.
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